Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek R Johnson

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumDavid N Soleimani-Meigooni, Ganna Blazhenets, Renaud La Joie, et al.
Annals of Nuclear Medicine|September 10, 2017
Uptake of AV-1451 in meningiomasTyler J Bruinsma, Derek R Johnson, Ping Fang, et al.
JAMA Neurology|June 1, 2026
Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma RatioAlicia Algeciras-Schimnich, Joshua A Bornhorst, Daniel J Figdore, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 8, 2026
Health system patterns of imaging and fluid biomarker testing in the era of anti-amyloid therapiesW Hudson Robb, Gurkiran Kaur, Steven Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
Cancers|November 13, 2025
Predicting Remaining Survival of Glioblastoma Patients with Radiomics Analysis Based on <sup>18</sup>F-DOPA PET ImagesJing Qian, Deanna Hasenauer, William G Breen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 9, 2025
Discrepancies between CSF biomarker and PET determinations of elevated brain amyloid and their prognostic significanceDavid S Knopman, Stephen D Weigand, Heather J Wiste, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2025
Calibration of multisite raters for prospective visual reads of amyloid PET scansDavid N Soleimani-Meigooni, Stefania Pezzoli, Ganna Blazhenets, et al.
Frontiers in Oncology|August 29, 2025
Analysis of imaging signatures in <sup>18</sup>F-DOPA PET of glioblastoma treated with dose-escalated radiotherapyJing Qian, Deanna H Pafundi, William G Breen, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumDavid N Soleimani-Meigooni, Ganna Blazhenets, Renaud La Joie, et al.
Annals of Nuclear Medicine|September 10, 2017
Uptake of AV-1451 in meningiomasTyler J Bruinsma, Derek R Johnson, Ping Fang, et al.
JAMA Neurology|June 1, 2026
Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma RatioAlicia Algeciras-Schimnich, Joshua A Bornhorst, Daniel J Figdore, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 8, 2026
Health system patterns of imaging and fluid biomarker testing in the era of anti-amyloid therapiesW Hudson Robb, Gurkiran Kaur, Steven Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
Cancers|November 13, 2025
Predicting Remaining Survival of Glioblastoma Patients with Radiomics Analysis Based on <sup>18</sup>F-DOPA PET ImagesJing Qian, Deanna Hasenauer, William G Breen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 9, 2025
Discrepancies between CSF biomarker and PET determinations of elevated brain amyloid and their prognostic significanceDavid S Knopman, Stephen D Weigand, Heather J Wiste, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2025
Calibration of multisite raters for prospective visual reads of amyloid PET scansDavid N Soleimani-Meigooni, Stefania Pezzoli, Ganna Blazhenets, et al.
Frontiers in Oncology|August 29, 2025
Analysis of imaging signatures in <sup>18</sup>F-DOPA PET of glioblastoma treated with dose-escalated radiotherapyJing Qian, Deanna H Pafundi, William G Breen, et al.
Pageof 15